Your browser doesn't support javascript.
loading
Subcutaneous Levodopa Infusion for Parkinson's Disease: 1-Year Data from the Open-Label BeyoND Study.
Poewe, Werner; Stocchi, Fabrizio; Arkadir, David; Ebersbach, Georg; Ellenbogen, Aaron L; Giladi, Nir; Isaacson, Stuart H; Kieburtz, Karl; LeWitt, Peter; Olanow, C Warren; Simuni, Tanya; Thomas, Astrid; Zlotogorski, Abraham; Adar, Liat; Case, Ryan; Oren, Sheila; Fuchs Orenbach, Shir; Rosenfeld, Olivia; Sasson, Nissim; Yardeni, Tami; Espay, Alberto J.
Afiliación
  • Poewe W; Department of Neurology, Medical University Innsbruck, Innsbruck, Austria.
  • Stocchi F; University and Institute for Research and Medical Care IRCCS San Raffaele, Rome, Italy.
  • Arkadir D; Department of Neurology, The Faculty of Medicine, Hadassah Medical Center, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Ebersbach G; Movement Disorder Clinic, Beelitz-Heilstaetten, Beelitz, Germany.
  • Ellenbogen AL; Michigan Institute for Neurological Disorders, Farmington Hills, Michigan, USA.
  • Giladi N; Tel Aviv Medical Center, Sackler School of Medicine, Sagol School of Neurosciences, Neurological Institute, Tel-Aviv University, Tel Aviv, Israel.
  • Isaacson SH; Parkinson's Disease and Movement Disorders Center of Boca Raton, Boca Raton, Florida, USA.
  • Kieburtz K; Departments of Neurology, Wayne State University School of Medicine and Henry Ford Hospital, Detroit, Michigan, USA.
  • LeWitt P; Clintrex Research Corp, Sarasota, Florida, USA.
  • Olanow CW; Departments of Neurology, Wayne State University School of Medicine and Henry Ford Hospital, Detroit, Michigan, USA.
  • Simuni T; Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Thomas A; Department of Neuroscience, Imaging and Clinical Sciences and Center of Advanced Studies and Technology CAST, University Chieti Pescara, Chieti, Italy.
  • Zlotogorski A; Department of Dermatology, The Faculty of Medicine, Hadassah Medical Center, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Adar L; NeuroDerm Ltd, Rehovot, Israel.
  • Case R; NeuroDerm Ltd, Rehovot, Israel.
  • Oren S; NeuroDerm Ltd, Rehovot, Israel.
  • Fuchs Orenbach S; NeuroDerm Ltd, Rehovot, Israel.
  • Rosenfeld O; NeuroDerm Ltd, Rehovot, Israel.
  • Sasson N; NeuroDerm Ltd, Rehovot, Israel.
  • Yardeni T; NeuroDerm Ltd, Rehovot, Israel.
  • Espay AJ; James J. and Joan A. Gardner Center for Parkinson's Disease and Movement Disorders, University of Cincinnati, Cincinnati, Ohio, USA.
Mov Disord ; 36(11): 2687-2692, 2021 11.
Article en En | MEDLINE | ID: mdl-34496081

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de Parkinson / Levodopa Tipo de estudio: Guideline Límite: Humans Idioma: En Revista: Mov Disord Asunto de la revista: NEUROLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Austria

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de Parkinson / Levodopa Tipo de estudio: Guideline Límite: Humans Idioma: En Revista: Mov Disord Asunto de la revista: NEUROLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Austria